Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study

BACKGROUND: Capecitabine monotherapy is a treatment option for selected patients with metastatic colorectal cancer (mCRC) and is administered to up to 17% of patients. Data are limited with regard to adverse events and dosing practices associated with capecitabine monotherapy in real-world situation...

Descripción completa

Detalles Bibliográficos
Autores principales: Leicher, Laura W., de Graaf, Jacques C., Coers, Wilko, Tascilar, Metin, de Groot, Jan Willem B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318322/
https://www.ncbi.nlm.nih.gov/pubmed/27848234
http://dx.doi.org/10.1007/s40268-016-0154-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318322/
https://www.ncbi.nlm.nih.gov/pubmed/27848234
http://dx.doi.org/10.1007/s40268-016-0154-8

Ejemplares similares